INFLIXIMAB SERUM TROUGH LEVEL AND CRP CHANGE ARE ASSOCIATED WITH CORTICOSTEROID-FREE REMISSION IN CROHN’S DISEASE: A POST-HOC ANALYSIS OF THE SONIC TRIAL

(1) U für Innere Medizin IV

(2) CHU

(3) U of California San Diego

(4) Evangelismos Hospital

(5) Mount Sinai Medical Center

(6) Janssen Biologics B.V.

(7) Janssen Services, LLC

(8) U Hospital Gasthuisberg



This item was part of the IBD I session at 20th United European Gastroenterology Week

This item can be cited as: Gut 2012; 61 (Suppl 3) A170